News

Funding for antimicrobial susceptibility testing

microphotonX presents its proprietary Raman-SBT technology at Bio Europe 2022

microphotonX contributes to proposing a new model in dermal regeneration

microphotonX appoints Dr. Lars Behrend as new CEO

Raman technology detects changes in blood cells associated with COVID-19 infection